Stereotaxic Irradiation of Hepatocellular Carcinoma

Inclusion Criteria: * Primitive liver cancer (hepatocellular carcinoma), proved by histology or diagnostic according to BCLC criteria * T1-3 N0 M0 * With only one intra hepatic lesion and dimensions between 1 cm and 6 cm (IRM or hepatic scanner) * Stereotaxic radiotherapy treatment approved in multidisciplinary consultation, the patient being rejected for standard therapeutic * Age \>= 18 ans * Previous anti tumoral treatment allowed but suspended since at least 15 days before the inclusion * OMS =\< 2 * Portal thrombosis allowed * Portal high blood pressure allowed * No contraindication of fiducials implantation, hemostasis disorders must be treated before the implantation * In case of underlying cirrhosis, only the Child-Pugh A is allowed * Life expectancy \>= 12 weeks * Women must have an active contraception during all the study * Patient affiliated to health insurance * Patient must sign the consent Exclusion Criteria: * T4 * Cirrhosis Child B and C * Hepatic lesion \< 1 cm or \> 6 cm * 2 hepatic lesions or more * Recurrent or metastatic disease * Patient already included in another therapeutic trial with an experimental molecule * Allergy to gold * Pregnant women or susceptible to be pregnant or breastfeeding * Unable for medical follow-up (geographic, social or mental reasons)